company background image
EVE

Eve Health Group ASX:EVE Stock Report

Last Price

AU$0.001

Market Cap

AU$4.3m

7D

-33.3%

1Y

-83.3%

Updated

19 May, 2022

Data

Company Financials
EVE fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

EVE Stock Overview

Eve Health Group Limited, together with its subsidiaries, engages in the production and marketing of nutrition, health, and wellness products in Australia, North America, China, and Asia.

Eve Health Group Peers

Price History & Performance

Summary of all time highs, changes and price drops for Eve Health Group
Historical stock prices
Current Share PriceAU$0.001
52 Week HighAU$0.006
52 Week LowAU$0.001
Beta1.48
1 Month Change-50.00%
3 Month Change-75.00%
1 Year Change-83.33%
3 Year Change-80.00%
5 Year Change-85.71%
Change since IPO-96.67%

Recent News & Updates

Shareholder Returns

EVEAU FoodAU Market
7D-33.3%1.7%3.5%
1Y-83.3%-6.1%2.1%

Return vs Industry: EVE underperformed the Australian Food industry which returned -6.1% over the past year.

Return vs Market: EVE underperformed the Australian Market which returned 2.1% over the past year.

Price Volatility

Is EVE's price volatile compared to industry and market?
EVE volatility
EVE Average Weekly Movement55.2%
Food Industry Average Movement6.0%
Market Average Movement9.5%
10% most volatile stocks in AU Market16.7%
10% least volatile stocks in AU Market4.3%

Stable Share Price: EVE is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 55% a week.

Volatility Over Time: EVE's weekly volatility has increased from 32% to 55% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003n/aBill Fryhttps://www.evehealthgroup.com.au

Eve Health Group Limited, together with its subsidiaries, engages in the production and marketing of nutrition, health, and wellness products in Australia, North America, China, and Asia. The company operates through three segments: Jenbrook, Meluka, and Investment. It provides organic tea tree oils and essential oils; and distributes botanical oils.

Eve Health Group Fundamentals Summary

How do Eve Health Group's earnings and revenue compare to its market cap?
EVE fundamental statistics
Market CapAU$4.31m
Earnings (TTM)-AU$5.45m
Revenue (TTM)AU$2.30m

1.9x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EVE income statement (TTM)
RevenueAU$2.30m
Cost of RevenueAU$1.19m
Gross ProfitAU$1.10m
Other ExpensesAU$6.55m
Earnings-AU$5.45m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.0013
Gross Margin48.01%
Net Profit Margin-237.50%
Debt/Equity Ratio8.2%

How did EVE perform over the long term?

See historical performance and comparison
New valuation analysis is now available for all ASX stocks. This is in beta.

Future Growth

How is Eve Health Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


10.0%

Forecasted Food, Beverage & Tobacco industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eve Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Eve Health Group performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-22.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EVE is currently unprofitable.

Growing Profit Margin: EVE is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: EVE is unprofitable, and losses have increased over the past 5 years at a rate of 22.5% per year.

Accelerating Growth: Unable to compare EVE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EVE is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (5.1%).


Return on Equity

High ROE: EVE has a negative Return on Equity (-77.18%), as it is currently unprofitable.


Financial Health

How is Eve Health Group's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: EVE's short term assets (A$2.5M) exceed its short term liabilities (A$771.0K).

Long Term Liabilities: EVE's short term assets (A$2.5M) exceed its long term liabilities (A$773.1K).


Debt to Equity History and Analysis

Debt Level: EVE has more cash than its total debt.

Reducing Debt: Insufficient data to determine if EVE's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EVE has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: EVE is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.


Dividend

What is Eve Health Group current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate EVE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EVE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EVE's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EVE's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as EVE has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

3.2yrs

Average management tenure


CEO

Bill Fry (55 yo)

2.42yrs

Tenure

AU$401,393

Compensation

Mr. Gregory William Fry, also known as Bill, serves as Managing Director and Chief Executive Officer at Eve Health Group Limited (formerly known as EVE Investments Limited) (formerly known as Energy Ventur...


CEO Compensation Analysis

Compensation vs Market: Bill's total compensation ($USD280.54K) is about average for companies of similar size in the Australian market ($USD285.05K).

Compensation vs Earnings: Bill's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: EVE's management team is considered experienced (3.2 years average tenure).


Board Members

Experienced Board: EVE's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.1%.


Top Shareholders

Company Information

Eve Health Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Eve Health Group Limited
  • Ticker: EVE
  • Exchange: ASX
  • Founded: 2003
  • Industry: Packaged Foods and Meats
  • Sector: Food, Beverage & Tobacco
  • Implied Market Cap: AU$4.310m
  • Shares outstanding: 4.31b
  • Website: https://www.evehealthgroup.com.au

Location

  • Eve Health Group Limited
  • 245 Churchill Avenue
  • Suite 1
  • Subiaco
  • Western Australia
  • 6008
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/19 00:00
End of Day Share Price2022/05/18 00:00
Earnings2021/12/31
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.